ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 7626 to 7645 of 14875 messages
Chat Pages: Latest  307  306  305  304  303  302  301  300  299  298  297  296  Older
DateSubjectAuthorDiscuss
08/12/2019
16:27
I have been having a good scout around looking where to invest my Xmas bonus. Can't find a rising chart anywhere.
ducatiman
06/12/2019
15:03
Surprised .9 has held. Somebody must want them.
ducatiman
06/12/2019
12:46
The pilot study is due to start this month and then it's a 3 month wait for the trial to end. Hope there are other trials in the pipeline while the 1st one is running otherwise it's going to be a long wait for any share price upturn.
digger2779
05/12/2019
23:12
AI Reveals New Breast Cancer Patterns each Linked to Different Treatment

AI algorithms that revealed five new breast cancer types that require personalized treatment, especially picking out those likely to benefit from immunotherapy. However, all other indications showed such treatments would not work for such patients.

lr2
05/12/2019
17:23
Very. No news on this trial yet then?
phillkay
05/12/2019
12:43
Sammy get lost if you have nothing constructive to say
sonie01
04/12/2019
19:03
Apologies dc it is frustrating
sonie01
04/12/2019
17:50
Language sonie!! Lol. Frustrating isn't it?
ducatiman
04/12/2019
17:47
Good posts Ged, LR2. A "sleeping giant"?
ducatiman
04/12/2019
15:43
Well shares are bloody irritating aren't they. Going up and down over and over gain and then flatlining when you think they might get interesting ;-)
yump
04/12/2019
15:13
Haha sorry! I remember counting the days ?
czc9
04/12/2019
14:23
Breast Cancer trials - TexRAD tech - South Korea - excellent results.



Better than nothing eh?

lr2
04/12/2019
14:14
Thanks for that. I was just trying to bring back a little bit of optimism. Now totally deflated. ;)
ged5
04/12/2019
14:11
Long term feedbackers will remember a CE Mark for Texrad being delayed by 9 months or so previously.
czc9
04/12/2019
13:43
From the July RNS:-

"By incorporating a dedicated, encrypted messaging function to Feedback's existing Cadran technology, the Directors believe it can become the only medical communication device on the market capable of sharing clinical grade medical imaging directly from a hospital PACS to mobile devices, ensuring the safe handling of patient data and facilitating a secure means of communication for clinicians across the UK. The Directors believe this new product will also be the only communication tool to be a CE marked medical device."

Better get on with securing Bleepa as a CE marked device. Three months to have got this done.

ged5
04/12/2019
13:21
We can't be too far off an announcement for Bleepa being CE marked. I've read that on average it takes 6-8 weeks. If that's true it should be any time now.

Some background reading:-

ged5
02/12/2019
20:58
If they got commercial deals in and outside 1.7p would be peanuts ducat.
czc9
02/12/2019
19:53
.7 very likely
sammyshares
02/12/2019
17:55
Unit then they announce the CE Mark and a definite date along with other trials and possible contracts both within and outside the NHS. You could see it hit 1.7 again in short order. Of course 0.7 could come first.
ducatiman
02/12/2019
17:21
Not sure who sammyshares is but the word 'expected' to start in the trial RNS isn't good news at all. If the trial doesn't start in December that's a further delay until any meaningful potential revenues for FDBK. You could see it hit the 0.7s again imho. Good luck all.
czc9
Chat Pages: Latest  307  306  305  304  303  302  301  300  299  298  297  296  Older

Your Recent History

Delayed Upgrade Clock